Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes

Study (n=59) found sensor glucose time in target range of 3.9–10 mmol/L favoured advanced hybrid closed loop over sensor-augmented pump + predictive low glucose management (70.4±8.1 vs 57.9 ± 11.7) by 12.5±8.5%(P <0.001), with greater improvement overnight (18.8±12.9%, P< 0.001).

Diabetes Care